<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="48705">Agonists</z:chebi> of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) exert protective effects in several models of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury, but their role in <z:hpo ids='HP_0001297'>stroke</z:hpo> is less clear </plain></SENT>
<SENT sid="1" pm="."><plain>The study investigates the effects of two PPAR-gamma <z:chebi fb="4" ids="48705">agonists</z:chebi>, <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> and <z:chebi fb="0" ids="8228">pioglitazone</z:chebi>, on <z:mp ids='MP_0003674'>oxidative stress</z:mp> and <z:mp ids='MP_0001845'>inflammatory response</z:mp> induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion in the rat hippocampus </plain></SENT>
<SENT sid="2" pm="."><plain>Common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 30 min followed by 1 h reperfusion resulted in a significant increase in the generation of reactive oxygen species, nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> and the end products of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation as well as markedly reduced endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> <z:chebi fb="0" ids="16856">glutathione</z:chebi> levels and up-regulated <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase activity </plain></SENT>
<SENT sid="3" pm="."><plain>Western blot analysis showed that <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion lead to an increase in cyclooxygenase-2 (COX-2) expression, as well activating p38 and p42/44 mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-kappaB) </plain></SENT>
<SENT sid="4" pm="."><plain>Pre-treatment with either <z:chebi fb="0" ids="50122">rosiglitazone</z:chebi> or <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> significantly reduced <z:mp ids='MP_0003674'>oxidative stress</z:mp>, COX-2 protein expression and activation of MAPKs and NF-kappaB </plain></SENT>
<SENT sid="5" pm="."><plain>Taken together, the results provide convincing evidence that PPAR-gamma <z:chebi fb="4" ids="48705">agonists</z:chebi> exert protective effects in a rat model of mild forebrain <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion injury by inhibiting <z:mp ids='MP_0003674'>oxidative stress</z:mp> and excessive <z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>